Save time and get answers to complex questions with AI chat
Zemdri nce gain exclusivity 2028 patent 2031?Patent expiration date of guselkumab?When does guselkumab patent expire?Sun pharma bortezomib?Brenzavvy discontinuation?
See the DrugPatentWatch profile for nexterone
Availability and Patents Nexterone is also known as intravenous mexiletine. According to DrugPatentWatch.com [1], mexiletine is a generic medication and not patented. However, it is not always easily available as an oral medication. Intravenous Form If a hospital has it in stock, it can be administered intravenously. However, its availability in this form often depends on specific medical circumstances and can be influenced by local regulations. Clinical Trials and Regulatory Approvals Researchers continue to explore new formulations and dosage forms of mexiletine, which may impact availability in the future. For the latest information on regulatory approvals, it's best to check with the relevant regulatory agencies. Alternatives and Analogues If nexterone is not available, patients may have other options. Mexiletine analogues, such as lidocaine, may be used as a treatment alternative for similar conditions. However, it's essential to consult a healthcare professional to discuss the best treatment options. Sources [1] DrugPatentWatch.com. Mexiletine. [Online]. Available at: https://www.drugpatentwatch.com/drug/mexiletine/. [2] Wikipedia. Mexiletine. [Online]. Available at: https://en.wikipedia.org/wiki/Mexiletine.
Other Questions About Nexterone :